Another milestone achieved! We’ve just wrapped up our second FDA pre-submission, where we received valuable, actionable feedback that brings us one step closer to our goal – bringing SalivIQ™ Strep A to market.

We’re very thankful to the FDA for their open engagement during our meeting, and we’re grateful to our regulatory consultants whose expertise helped guide us through this process.

With a clear and fast path forward, we’re moving ahead with excitement and momentum. On to the next milestone!